Abstract #2116

Contrast-enhanced MRI radiomics for predicting therapeutic response to transcatheter arterial chemoembolization in HCC

Ying Zhao¹, Ailian Liu¹, Tao Lin¹, Qingwei Song¹, Yu Yao^2,3, Han Wen^2,3, Xin Li⁴, Yan Guo⁴, and Tingfan Wu⁴

¹The First Affiliated Hospital of Dalian Medical University, Dalian, China, ²Chengdu Institute of Computer Application, Chinese Academy of Sciences, Chengdu, China, ³University of Chinese Academy of Sciences, Beijing, China, ⁴GE Healthcare (China), ShangHai, China

In the present study, contrast-enhanced MRI radiomics was demonstrated to be capable to predict therapeutic response in hepatocellular carcinoma treated with transcatheter arterial chemoembolization, which will provide some guidance for treatment decisions.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.